MTOR and chordoma: Further imaging revealed growth of these lesions over the next 6 months, and he was initiated on imatinib and sirolimus, based on his underlying diagnosis of TS and the limited evidence of the use of PDGFR inhibitors and mTOR inhibitors in chordoma [2, 3].